PI-88, a heparanase inhibitor showing promising evidence of patient benefit in phase II clinical trials.

Gautam, AM, Ferro, V, Wilson, EA, Freeman, C and Parish, C (2005). PI-88, a heparanase inhibitor showing promising evidence of patient benefit in phase II clinical trials.. In: Clinical Cancer Research. AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics, Philadelphia Pa, (9037S-9037S). Nov 14-18, 2005.

Author Gautam, AM
Ferro, V
Wilson, EA
Freeman, C
Parish, C
Title of paper PI-88, a heparanase inhibitor showing promising evidence of patient benefit in phase II clinical trials.
Conference name AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics
Conference location Philadelphia Pa
Conference dates Nov 14-18, 2005
Proceedings title Clinical Cancer Research   Check publisher's open access policy
Journal name Clinical Cancer Research   Check publisher's open access policy
Publication Year 2005
Sub-type Published abstract
ISSN 1078-0432
Volume 11
Issue 24
Start page 9037S
End page 9037S
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: School of Chemistry and Molecular Biosciences
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Sun, 11 Sep 2011, 13:58:06 EST by System User on behalf of Scholarly Communication and Digitisation Service